NEW AMBRX BIOPHARMA INC (AMAM)
US6418711080 - Common Stock
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -82.63M | -78.00M | -68.29M | -17.84M | -22.31M | |||
| Depreciation Amortization | 1.80M | 1.80M | 2.15M | 1.94M | 2.05M | |||
| Change In Working Capital | -8.43M | -10.62M | 3.64M | -7.38M | 14.18M | |||
| Interest Paid | 0.00 | 960.00K | 0.00 | 10.00K | 0.00 | |||
| Taxes Paid | 320.00K | 320.00K | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 15.77M | 18.14M | 17.85M | 2.70M | 3.32M | |||
| OPERATING CASH FLOW | -73.47M | -68.68M | -44.64M | -20.58M | -2.77M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.23M | -1.05M | -3.21M | -250.00K | -50.00K | |||
| Other Investing Activity | 63.62M | -45.66M | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | 62.38M | -46.72M | -3.21M | -250.00K | -50.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Stock Issued/Repurchased | 170.54M | 0.00 | 148.39M | 95.68M | 0.00 | |||
| Other Financing Activity | 0.00 | 930.00K | -20.97M | 0.00 | 0.00 | |||
| FINANCING CASH FLOW | 170.54M | 930.00K | 127.43M | 95.68M | 0.00 | |||
| Exchange Rate Effect | N/A | N/A | 50.00K | 170.00K | -40.00K | |||
| CHANGE IN CASH | 159.45M | -114.47M | 79.63M | 75.02M | -2.86M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -73.47M | -68.68M | -44.64M | -20.58M | -2.77M | |||
| Capital Expenditure | -1.23M | -1.05M | -3.21M | -250.00K | -50.00K | |||
| FREE CASH FLOW | -74.70M | -69.73M | -47.85M | -20.83M | -2.82M | |||
All data in USD